Home・Stock List・Penumbra Inc

Penumbra Inc

Closed

SectorHealthcare

319.97 0.93

Buy Sell

Overview

Share price change

24h

Current

Min

317.02

Max

320.29

Key metrics
By Trading Economics
Income	2.2M 35M
Sales	15M 390M
P/E Sector Avg	79.352 56.597
EPS	0.88
Profit margin	8.925
Employees	4,700
EBITDA	5.5M 52M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+12.8% upside

Dividends
By Acuity
Next Earnings	4 Nov 2026

Market Stats
By TradingEconomics
Market Cap	124M 13B
Previous open	319.04
Previous close	319.97

News Sentiment

By Acuity

50%

112 / 339 Healthcare

Penumbra Inc Chart

Past performance is not a reliable indicator of future results.

Related News

28 Aug 2026, 19:36 UTC

Penumbra Inc shares are advancing during Friday's session. The stock's performance aligns with ongoing inflation concerns highlighted by recent Fed comments.

27 Aug 2026, 21:01 UTC

Penumbra Inc shares are higher in after-market trading. No specific news was identified to explain this movement, though broader market sentiment remains steady.

26 Aug 2026, 20:08 UTC

Penumbra Inc's shares are lower today, impacted by a notable decline in the Health Care Equipment sub-sector. No specific news has been identified.

25 Aug 2026, 23:01 UTC

Penumbra Inc shares are higher in after-market trading, recovering from earlier declines amid broader market resilience despite fluctuations linked to falling crude oil prices.

24 Aug 2026, 23:11 UTC

Penumbra Inc shares are higher in after-market hours, reflecting notable gains since Monday's close and reaching a session high within its one-month trading range.

22 Aug 2026, 00:02 UTC

Penumbra Inc shares are higher in after-market hours, rebounding alongside major stocks and remaining above the 20-day moving average. No specific news was identified.

21 Aug 2026, 23:31 UTC

Penumbra Inc's shares are higher in after-market trading, rebounding from an initial decline. The stock is above its 20-day moving average.

17 Aug 2026, 19:36 UTC

Correlated Moves

Penumbra Inc. shares are lower today, reflecting broader market declines amid rising bond yields and geopolitical tensions. The stock is near its one-month range high.

10 Aug 2026, 19:36 UTC

Correlated Moves

Penumbra Inc shares are higher today, supported by positive trends in the health care equipment sector and the performance of related ETFs.

8 Aug 2026, 00:02 UTC

Penumbra Inc shares are trading higher in after-market hours, maintaining strength above the 20-day moving average and near the upper end of their one-month range.

7 Aug 2026, 19:56 UTC

Penumbra Inc. shares are lower today, despite earlier gains, amid a broader market influenced by a disappointing jobs report and shifting monetary policy sentiment.

6 Aug 2026, 19:36 UTC

Penumbra Inc shares are modestly higher today, maintaining an upward trajectory. No specific company news was identified to explain the price movement.

5 Aug 2026, 21:03 UTC

Penumbra Inc shares are higher in after-market hours, though no specific news explains the movement. The stock remains above its 20-day moving average.

4 Aug 2026, 19:36 UTC

Penumbra Inc shares are higher today, reflecting a slight gain since Monday. The stock remains above its 20-day moving average amid broader market trends.

3 Aug 2026, 21:01 UTC

Penumbra Inc. shares are lower in after-market trading, despite gains in the broader market. The decline began shortly after Monday's close.

24 Jul 2026, 16:36 UTC

Correlated Moves

Penumbra Inc's shares are higher today, supported by gains in the medical devices sector and a decline in oil prices easing inflation concerns.

Peer Comparison

Price change

Penumbra Inc Forecast

Price Target

By TipRanks

12.8% upside

12 Months Forecast

Average 358.4 USD 12.8%

High 374 USD

Low 320 USD

Based on 6 Wall Street analysts offering 12 month price targets forPenumbra Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to Penumbra Inc - Dist in the past 3 months.

Sentiment

By Acuity

112 / 339 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.